Ads for Sepracor’s Lunesta, Novartis Corporation’s Tasigna Among Those Warned by FDA

September 3, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Sept. 3 (Reuters) - The following are details of some recent FDA warnings sent to drugmakers over misleading or inappropriate advertising, along with the dates the letters were made public.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)